Selectis Health (GBCS) Gross Margin (2018 - 2025)

Selectis Health has disclosed Gross Margin across 8 years of filings, most recently posting 27.61% for Q4 2025.

• Gross Margin for Q4 2025 came in at 27.61%, up 327.0% year-over-year; the trailing twelve-month figure through Dec 2025 was 23.36% (up 24.0% YoY), and the FY2025 annual result was 23.36%, up 24.0% from the prior year.
• Gross Margin came in at 27.61% for Q4 2025 at Selectis Health, up from 21.41% in the prior quarter.
• In the past five years, Gross Margin ranged from a high of 39.69% in Q3 2021 to a low of 11.41% in Q1 2023.
• The 5-year median for Gross Margin is 22.6% (2021), against an average of 23.66%.
• Across the five-year window, Gross Margin slumped 2570 bps in 2021 and soared 1635 bps in 2022, its largest moves.
• Selectis Health's Gross Margin stood at 13.08% in 2021, then surged by 51 bps to 19.75% in 2022, then declined by 20 bps to 15.87% in 2023, then soared by 53 bps to 24.34% in 2024, then increased by 13 bps to 27.61% in 2025.
• The last three Gross Margin figures came in at 27.61% (Q4 2025), 21.41% (Q3 2025), and 21.89% (Q2 2025), per Business Quant data.